Kynam Capital Management, LP Legend Biotech Corp Transaction History
Kynam Capital Management, LP
- $1.19 Billion
- Q1 2025
A detailed history of Kynam Capital Management, LP transactions in Legend Biotech Corp stock. As of the latest transaction made, Kynam Capital Management, LP holds 610,000 shares of LEGN stock, worth $16.9 Million. This represents 1.74% of its overall portfolio holdings.
Number of Shares
610,000Holding current value
$16.9 Million% of portfolio
1.74%Shares
1 transactions
Others Institutions Holding LEGN
# of Institutions
228Shares Held
73.8MCall Options Held
208KPut Options Held
338K-
Westfield Capital Management CO LP Boston, MA6.92MShares$192 Million1.21% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.73MShares$186 Million0.03% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$166 Million6.23% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$158 Million0.01% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.75MShares$104 Million5.57% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $4.64B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...